← Back to patent-cliff list
CAS 38780-40-4
Codes: MIRI-010, PT-112-001
Application context (from source-drug indications)
Hepatocellular carcinomaMiriplatin Hydrate胸腺瘤Imifoplatin胸腺上皮肿瘤Imifoplatin胸腺肿瘤ImifoplatinSolid tumourImifoplatinNon-small cell lung cancerImifoplatinHepatocellular carcinomaImifoplatin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Miriplatin Hydrate | Tier C — Watch / trade | - |
| Imifoplatin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
PT-112→PT-112-001
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.